Skip to content
TerraPower Isotopes
-
Lantheus considers US$7B takeover offer from Curium Pharma
The proposed acquisition comes at a time when radiopharmaceuticals are attracting unprecedented attention from investors, healthcare providers, and pharmaceutical manufacturers.
-
TerraPower Isotopes breaks ground on landmark Actinium-225 manufacturing facility in Philadelphia
The new 250,000-square-foot (23,226-square-metre) Bellwether Laboratory will significantly expand global production capacity for actinium-225 (Ac-225).